Literature DB >> 20580358

Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial.

Evangelos G Papanikolaou1, Human Fatemi, Michel Camus, Dimitra Kyrou, Nikos P Polyzos, Peter Humaidan, Basil Tarlatzis, Paul Devroey, Herman Tournaye.   

Abstract

In a prospective randomized controlled trial, 119 patients were randomized to receive either recombinant hCG (250 μg) or urinary-derived hCG (10,000 IU) for final oocyte maturation in an antagonist protocol with a fixed dose of recombinant FSH (187.5 IU) and predefined single blastocyst transfer. The delivery rate was improved in the recombinant hCG group compared with the urinary-derived hCG group (44.1 vs. 25.7, respectively); however, adequately powered randomized controlled trials are justified to ascertain whether this difference is true.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20580358     DOI： 10.1016/j.fertnstert.2010.04.077

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.

Authors:  Mohamed A Youssef; Ahmed M Abou-Setta; Wai Sun Lam
Journal:  Cochrane Database Syst Rev       Date:  2016-04-23

Review 2.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 3.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

4.  A LC-MS All-in-One Workflow for Site-Specific Location, Identification and Quantification of N-/O- Glycosylation in Human Chorionic Gonadotropin Drug Products.

Authors:  Hongbin Zhu; Chen Qiu; Ashley C Ruth; David A Keire; Hongping Ye
Journal:  AAPS J       Date:  2017-02-28       Impact factor: 4.009

5.  Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial.

Authors:  Tahereh Madani; Ladan Mohammadi Yeganeh; Zahra Ezabadi; Fatemeh Hasani; Mohammad Chehrazi
Journal:  J Assist Reprod Genet       Date:  2012-12-29       Impact factor: 3.412

6.  Pregnancy rates with recombinant versus urinary human chorionic gonadotropin in in vitro fertilization: an observational study.

Authors:  József Zeke; Katalin Kanyó; Helga Zeke; Aron Cseh; Barna Vásárhelyi; András Szilágyi; János Konc
Journal:  ScientificWorldJournal       Date:  2011-10-19

7.  Exploring the Chemical Space of Protein Glycosylation in Noncovalent Protein Complexes: An Expedition along Different Structural Levels of Human Chorionic Gonadotropin by Employing Mass Spectrometry.

Authors:  Maximilian Lebede; Fiammetta Di Marco; Wolfgang Esser-Skala; René Hennig; Therese Wohlschlager; Christian G Huber
Journal:  Anal Chem       Date:  2021-07-21       Impact factor: 6.986
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.